Oppenheimer Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Oppenheimer Asset Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-776	Closed	-$28K	–	1325
2020 Q1	$28K	Sell	776 -31	-4%	-$1.2K	﹤0.01%	1347
2019 Q4	$33K	Buy	807 +36	+5%	+$1.34K	﹤0.01%	1395
2019 Q3	$27K	Buy	771 +410	+114%	+$13.5K	﹤0.01%	1425
2019 Q2	$11K	Sell	361 -43	-11%	-$1.28K	﹤0.01%	1518
2019 Q1	$12K	Sell	404 -8,324	-95%	-$239K	﹤0.01%	1485
2018 Q4	$269K	Sell	8,728 -782	-8%	-$28.5K	0.01%	930
2018 Q3	$361K	Sell	9,510 -1,202	-11%	-$45.5K	0.01%	909
2018 Q2	$411K	Sell	10,712 -353	-3%	-$11.9K	0.01%	861
2018 Q1	$374K	Buy	11,065 +6,867	+164%	+$263K	0.01%	861
2017 Q4	$210K	Hold	4,198	–	–	0.01%	1033
2017 Q3	$210K	Sell	4,198 -92	-2%	-$4.7K	0.01%	1039
2017 Q2	$227K	Sell	4,290 -4,435	-51%	-$238K	0.01%	1003
2017 Q1	$485K	Buy	+8,725	New	+$481K	0.01%	794

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Oppenheimer Asset Management's PBH Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2020, closing a stake of 776 shares — an estimated $28K sold.

Oppenheimer Asset Management first reported a position in PBH in Q1 2017 and held it in 13 quarters. The position peaked at $485K in Q1 2017. 253 funds tracked by Wall St. Rank hold PBH as of Q2 2020.

Oppenheimer Asset Management reported no remaining Prestige Consumer Healthcare position as of Q2 2020 after selling out during the quarter.
Oppenheimer Asset Management sold 776 Prestige Consumer Healthcare shares in Q2 2020, an estimated $28K.
Oppenheimer Asset Management first reported a position in Prestige Consumer Healthcare in Q1 2017 and held it in 13 quarters.
Oppenheimer Asset Management's Prestige Consumer Healthcare position peaked at $485K in Q1 2017.
253 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.